郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Spatial Chemical Stimulation Control in Microenvironment by Microfluidic Probe Integrated Device for Cell-Based Assay.

期刊：PloS one发表年份：2016作者：Masayuki Horayama; Kenta Shinha; Kazuya Kabayama; Teruo Fujii; Hiroshi Kimura
阅读更多 →

药效评价Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs.

期刊：International journal of nanomedicine发表年份：2016作者：Antonia Mr Franco; Iryna Grafova; Fabiane V Soares; Gennaro Gentile; Claudia Dc Wyrepkowski; Marcos A Bolson; Ézio Sargentini; Cosimo Carfagna; Markku Leskelä; Andriy Grafov
阅读更多 →

药效评价Antibody humanization by molecular dynamics simulations-in-silico guided selection of critical backmutations.

期刊：Journal of molecular recognition : JMR发表年份：2016作者：Christian Margreitter; Patrick Mayrhofer; Renate Kunert; Chris Oostenbrink
阅读更多 →

药效评价Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?

期刊：Toxicological sciences : an official journal of the Society of Toxicology发表年份：2016作者：Jason R Slizgi; Yang Lu; Kenneth R Brouwer; Robert L St Claire; Kimberly M Freeman; Maxwell Pan; William J Brock; Kim L R Brouwer
阅读更多 →